...
机译:尿激酶特异性杨氏菌病毒诱导原位小鼠模型中的细胞融合/细胞凋亡。
Department of Otolaryngology ‐ Head and Neck SurgeryNational Defense Medical CollegeSaitama Japan;
Department of Otolaryngology ‐ Head and Neck SurgeryNational Defense Medical CollegeSaitama Japan;
Department of Otolaryngology ‐ Head and Neck SurgeryKitasato University School of;
Department of Otolaryngology ‐ Head and Neck SurgeryNational Defense Medical CollegeSaitama Japan;
Department of Otolaryngology ‐ Head and Neck SurgeryNational Defense Medical CollegeSaitama Japan;
Department of Otolaryngology ‐ Head and Neck SurgeryNational Defense Medical CollegeSaitama Japan;
Section of Gene Medicine R&
D CenterID Pharma Co. Ltd.Tokyo Japan;
R&
D Laboratory for Innovative Biotherapeutics Science Graduate School of Pharmaceutical;
Department of SurgeryToho University School of MedicineTokyo Japan;
Department of Otolaryngology ‐ Head and Neck SurgeryNational Defense Medical CollegeSaitama Japan;
anaplastic thyroid carcinoma; oncolytic virus; Sendai virus; urokinase‐type plasminogen activator; virotherapy;
机译:尿激酶特异性杨氏菌病毒诱导原位小鼠模型中的细胞融合/细胞凋亡。
机译:Sentinel淋巴结靶向治疗肉瘤仙奈语病毒在原位裸鼠模型中抑制了头颈鳞状细胞癌的微转移
机译:oncolytic Sendai病毒诱导的肿瘤特异性免疫反应器在免疫活性小鼠模型中抑制鳞状细胞癌的“模拟转移”
机译:伏立诺他通过DR5增强间变性甲状腺癌细胞中TRAIL诱导的凋亡。
机译:分析有助于溶瘤性水疱性口炎病毒诱导细胞凋亡的宿主基因产物。
机译:与编码TRAIL和IL-12基因的溶瘤腺病毒联合治疗在体外和原位移植小鼠模型中均能显着抑制人肝细胞癌
机译:勘误:与编码TRAIL和IL-12基因的溶瘤腺病毒联合治疗在体外和原位移植小鼠模型中均能显着抑制人肝细胞癌